COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter Registry (CONFIRM)

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Completed
CT.gov ID
NCT01443637
Collaborator
(none)
34,000
20
153
1700
11.1

Study Details

Study Description

Brief Summary

The CONFIRM study was developed to examine the prognostic value of cardiac computed tomographic angiography (CCTA) findings for prediction of future adverse cardiac events related to coronary artery disease (CAD) in a large, international patient population. The purpose of this multicenter registry is to correlate coronary and non-coronary cardiac findings by CCTA with demographic and clinical data for refinement of risk stratification of individuals with suspected or known CAD.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Coronary computed tomographic angiography (CCTA) of 64-detector rows or greater represents a novel noninvasive anatomic method for evaluation of patients with suspected coronary artery disease (CAD). Early studies suggest a potential for prognostic risk assessment by CCTA findings but were limited by small patient cohorts or single centers. The CONFIRM Registry is a large, prospective, multinational dynamic observational study of patients undergoing CCTA. The primary aim of CONFIRM is to determine the prognostic value of CCTA findings for the prediction of future adverse CAD events.

    The CONFIRM registry currently represents 27,125 consecutive patients at 12 cluster sites in 6 countries in North America, Europe, and Asia. CONFIRM sites were chosen on the basis of adequate CCTA volume, site CCTA proficiency, and local demographic characteristics and medical facilities to ensure a broad-based sample of patients. Patients comprising the present CONFIRM cohort include those with suspected but without known CAD, with known CAD, or asymptomatic persons undergoing CAD evaluation. A data dictionary comprising a wide array of demographic, clinical, and CCTA findings was developed by the CONFIRM investigators and is uniformly used for all patients. Patients are followed up after CCTA performance to identify adverse CAD events, including death, myocardial infarction, unstable angina, target vessel revascularization, and CAD-related hospitalization.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    34000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    COronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter Registry
    Actual Study Start Date :
    Jun 1, 2003
    Actual Primary Completion Date :
    Mar 1, 2016
    Actual Study Completion Date :
    Mar 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Coronary CT Angiography (CCTA)

    Patients included in the CONFIRM Registry are those that have previously undergone clinically-indicated CCTA as part of their standard of care.

    Outcome Measures

    Primary Outcome Measures

    1. Coronary and non-coronary cardiac findings by CCTA [yearly]

      Identify, quantify, and integrate coronary and noncoronary cardiac findings by Coronary computed tomographic angiography (CCTA) with demographic and clinical data for refinement of risk stratification of persons with suspected or known CAD.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    All consecutive patients at cluster sites meeting all inclusion criteria undergoing CCTA of 64-detector rows or greater will be included within the CONFIRM registry.

    Inclusion Criteria:
    1. Age > 18 years

    2. Evaluation by CCTA with 64-detector rows or greater for CAD evaluation as part of standard of care

    3. Interpretable CCTA

    4. Prospective data collection for CAD risk factors.

    Exclusion Criteria:

    No explicit patient exclusion criteria are defined.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cedars-Sinai Medical Center Los Angeles California United States 90048
    2 Cardiovascular Medical Group of Southern California Los Angeles California United States 90210
    3 Harbor UCLA Los Angeles California United States 90502
    4 Walter Reed Army Medical Center Washington District of Columbia United States 20889
    5 Baptist Cardiac and Vascular Institute Miami Florida United States 33176
    6 Emory University Atlanta Georgia United States 30322
    7 Henry Ford Hospital Detroit Michigan United States 48202
    8 William Beaumont Hospital Royal Oak Michigan United States 48073
    9 Capital Cardiology Associates Albany New York United States 12208
    10 Weill Cornell Medical Center New York New York United States 10021
    11 Tenessee Heart and Vascular Institute Hendersonville Tennessee United States 37035
    12 Medical University Innsbruck Innsbruck Austria
    13 Providence Health Care Vancouver British Columbia Canada
    14 Ottawa Heart Institute Ottawa Ontario Canada
    15 University of Giessen Giessen Germany
    16 Deutsches Herzzentrum Munchen Munich Germany
    17 University of Parma Parma Italy
    18 Seoul National University College of Medicine Seoul Korea, Republic of
    19 Severance Cardiovascular Hospital Seoul Korea, Republic of
    20 University Hospital of Zurich Zurich Switzerland

    Sponsors and Collaborators

    • Weill Medical College of Cornell University

    Investigators

    • Principal Investigator: Leslee J Shaw, PhD, Weill Medical College of Cornell University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Weill Medical College of Cornell University
    ClinicalTrials.gov Identifier:
    NCT01443637
    Other Study ID Numbers:
    • 1310014468
    First Posted:
    Sep 30, 2011
    Last Update Posted:
    Jan 13, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Weill Medical College of Cornell University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 13, 2022